Propafenone Hydrochloride Capsule, Extended Release
Product Images NDC 59651-276

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Propafenone Hydrochloride (NDC 59651-276). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Propafenone-fig1 (Propafenone Fig1)

A Kaplan-Meier survival curve chart displaying the proportion of patients without an event over time in days, comparing placebo with three strengths of propafenone hydrochloride extended-release capsules (225 mg, 325 mg, and 425 mg). The graph includes statistical significance values (P < 0.001 and P = 0.014) and notes patient numbers at risk over various time points up to 300 days, with a patient closeout indicated at Week 39 (Day 273).*

FDA Label Image

Package Label-principal Display Panel (225 mg (60 Capsules Bottle))

Label for Propafenone Hydrochloride Extended-Release Capsules, USP 225 mg, oral dosage form. The label indicates a bottle containing 60 capsules, distributed by Aurobindo Pharma USA, Inc., made in India. Storage instructions and warnings about the seal are also visible, along with an NDC number and a barcode.*

FDA Label Image

Package Label-principal Display Panel (325 mg (60 Capsules Bottle))

Label for Propafenone Hydrochloride Extended-Release Capsules USP 325 mg, oral dosage form, in a package of 60 capsules. The label indicates the drug is distributed by Aurobindo Pharma USA, Inc. and made in India. It includes storage instructions, dosage information reference, and a barcode on the right side.*

FDA Label Image

Package Label-principal Display Panel (425 mg (60 Capsules Bottle))

Label for Propafenone Hydrochloride Extended-Release Capsules, USP 425 mg, oral capsules by Aurobindo Pharma Limited. The label states a 60-capsule count, includes storage instructions, a barcode, and distributor information for Aurobindo Pharma USA, Inc. The NDC number is 59651-278-60.*

FDA Label Image

Chemical Structure (Propafenone Str)

Chemical structure diagram of Propafenone Hydrochloride showing its molecular arrangement including phenyl rings, ether and amine functional groups, and the hydrochloride moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.